GLOBAL CORD BLOOD CORPORATION Global Cord Blood Corporation Share Price
Equities
CORBF
KYG393421030
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.25 USD | 0.00% |
|
0.00% | +2.46% |
| 2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
| 2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
| Sales 2021 | 1.16B 160M 13.34B | Sales 2022 | 1.24B 172M 14.31B | Capitalization | 2.97B 410M 34.15B |
|---|---|---|---|---|---|
| Net income 2021 | 508M 70.11M 5.85B | Net income 2022 | 501M 69.14M 5.76B | EV / Sales 2021 | -2.13 x |
| Net cash position 2021 | 6.07B 838M 69.89B | Net cash position 2022 | 6.66B 919M 76.65B | EV / Sales 2022 | -2.97 x |
| P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | 1,202 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
More Fundamentals
* Assessed data
More news
More press releases
| Current month | -7.41% | ||
| 1 month | -7.41% | ||
| Current year | +2.46% |
1 week
1.20
1.35
1 month
1.201.80
Current year
0.982.33
1 year
0.022.33
3 years
0.026.31
5 years
0.026.98
10 years
0.0214.95
| Managers | Title | Age | Since |
|---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 01/09/01 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 01/09/01 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 01/04/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 01/09/01 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 01/09/01 |
| Director/Board Member | 56 | 01/09/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 1.25 | 0.00% | 8,226 |
| 25/24/25 | 1.25 | -7.41% | 32,683 |
| 22/24/22 | 1.35 | +8.00% | 3,733 |
Delayed Quote OTC Markets, April 27, 2024 at 12:34 am IST
More quotes
Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.46% | 167M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -3.97% | 11.66B | |
| -1.42% | 11.72B | |
| -31.75% | 11.77B |
- Stock Market
- Equities
- CORBF Stock
